Howard Shapland,Scott Glickman,Christian G. Krueger,Amy B. Howell,Jess D. Reed,克里斯汀‧G‧克魯格,Amy B. Howell,艾米‧B‧豪厄爾,Jess D. Reed,杰斯‧D‧里德
申请号：
HK18108094
公开号：
HK1248532A1
申请日:
2018.06.22
申请国别(地区):
HK
年份:
2018
代理人:
摘要：
Provided is a pharmaceutical composition for use in a method of preventing or treating a urinary tract infection (UTI), chronic cystitis, overactive bladder, partial bladder obstruction or urethritis, said composition comprising one or more oligomeric tannins, selected from proanthocyanidins and/or hydrolysable tannins, where in said method said composition is administered intraurethrally, intravesically, intraureterally and/or intrarenally, as well as a pharmaceutical composition for use in a method of preventing or treating bladder cancer, where in said method said composition is administered intravesically, said composition comprising one or more oligomeric tannins, selected from proanthocyanidins and/or hydrolysable tannins, wherein said tannins are bound to an anti-cancer agent and/or liposomes containing an anti-cancer agent, together with compositions related thereto.
